These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36367536)

  • 1. A Reactive Oxygen Species-Scavenging 'Stealth' Polymer, Poly(thioglycidyl glycerol), Outperforms Poly(ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances Protein Stability to Environmental and Biological Stressors.
    d'Arcy R; El Mohtadi F; Francini N; DeJulius CR; Back H; Gennari A; Geven M; Lopez-Cavestany M; Turhan ZY; Yu F; Lee JB; King MR; Kagan L; Duvall CL; Tirelli N
    J Am Chem Soc; 2022 Nov; 144(46):21304-21317. PubMed ID: 36367536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main Chain Polysulfoxides as Active 'Stealth' Polymers with Additional Antioxidant and Anti-Inflammatory Behaviour.
    El Mohtadi F; d'Arcy R; Yang X; Turhan ZY; Alshamsan A; Tirelli N
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart.
    Ozer I; Kelly G; Gu R; Li X; Zakharov N; Sirohi P; Nair SK; Collier JH; Hershfield MS; Hucknall AM; Chilkoti A
    Adv Sci (Weinh); 2022 Apr; 9(11):e2103672. PubMed ID: 35133079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer Based Protein Therapeutics.
    Bhawani SA; Husaini A; Ahmad FB; Asaruddin MR
    Curr Protein Pept Sci; 2018; 19(10):972-982. PubMed ID: 28828988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One to one comparison of cell-free synthesized erythropoietin conjugates modified with linear polyglycerol and polyethylene glycol.
    Pouyan P; Zemella A; Schloßhauer JL; Walter RM; Haag R; Kubick S
    Sci Rep; 2023 Apr; 13(1):6394. PubMed ID: 37076514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
    Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Low Can You Go? Low Densities of Poly(ethylene glycol) Surfactants Attract Stealth Proteins.
    Seneca S; Simon J; Weber C; Ghazaryan A; Ethirajan A; Mailaender V; Morsbach S; Landfester K
    Macromol Biosci; 2018 Sep; 18(9):e1800075. PubMed ID: 29943446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y; Shimizu T; Abu Lila AS; Ishida T; Kiwada H
    Biol Pharm Bull; 2015; 38(3):417-24. PubMed ID: 25757923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of PolyPEG to interferon alpha extends serum half-life while maintaining low viscosity of the conjugate.
    Podobnik B; Helk B; Smilović V; Škrajnar Š; Fidler K; Jevševar S; Godwin A; Williams P
    Bioconjug Chem; 2015 Mar; 26(3):452-9. PubMed ID: 25629733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglycerol and Poly(ethylene glycol) exhibit different effects on pharmacokinetics and antibody generation when grafted to nanoparticle surfaces.
    Shin K; Suh HW; Grundler J; Lynn AY; Pothupitiya JU; Moscato ZM; Reschke M; Bracaglia LG; Piotrowski-Daspit AS; Saltzman WM
    Biomaterials; 2022 Aug; 287():121676. PubMed ID: 35849999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS; Uehara Y; Ishida T; Kiwada H
    J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profile.
    Siddalingappa B; Benson HA; Brown DH; Batty KT; Chen Y
    PLoS One; 2015; 10(3):e0118824. PubMed ID: 25799413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance.
    Shiraishi K; Kawano K; Maitani Y; Aoshi T; Ishii KJ; Sanada Y; Mochizuki S; Sakurai K; Yokoyama M
    J Control Release; 2016 Jul; 234():59-67. PubMed ID: 27164541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
    Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
    Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brush Conformation of Polyethylene Glycol Determines the Stealth Effect of Nanocarriers in the Low Protein Adsorption Regime.
    Li M; Jiang S; Simon J; Paßlick D; Frey ML; Wagner M; Mailänder V; Crespy D; Landfester K
    Nano Lett; 2021 Feb; 21(4):1591-1598. PubMed ID: 33560851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T; Abu Lila AS; Fujita R; Awata M; Kawanishi M; Hashimoto Y; Okuhira K; Ishima Y; Ishida T
    Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(Oxanorbornene)-Protein Conjugates Prepared by Grafting-to ROMP as Alternatives for PEG.
    Davis E; Caparco AA; Steinmetz NF; Pokorski JK
    Macromol Biosci; 2024 Feb; 24(2):e2300255. PubMed ID: 37688508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy.
    Liu M; Li J; Zhao D; Yan N; Zhang H; Liu M; Tang X; Hu Y; Ding J; Zhang N; Liu X; Deng Y; Song Y; Zhao X
    Biomaterials; 2022 Apr; 283():121415. PubMed ID: 35217484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.